The Department of Radiation Oncology is comprised of more than 30 scientists, physicians, physicists and physician-scientists dedicated to uncovering the genetic causes of cancer, developing new technologies and approaches to improve treatment, and to personalizing therapy so that each patient can receive a specified combination of therapies that will best treat their tumor.

Learn more about the scientists and research being done in BASIC AND TRANSLATIONAL BIOLOGY and CLINICAL TRIALS.

Help support our fight against cancer.


Basic and Translational Research

Basic science research provides the foundation for understanding the molecular and genetic causes of cancer development and response to treatment. Scientist in the Division of Radiation Cancer Biology are developing and using advanced genetic, genomic, computational, bioinformatics, and molecular approaches to understand these mechanisms and to identify the genetic vulnerabilities of cancer. Using this information, we can identify new drug targets or biomarkers for current treatments and develop new therapies and therapeutic strategies that personalize treatment based on the genetic mechanisms of each patient’s tumor.

Because the Department is comprised of both scientists and physicians, we move our discoveries in the laboratory rapidly into the clinic – meaning our patients benefit from ground-breaking discoveries…faster.  Translational research in the Department is focused on identifying genetic biomarkers to predict therapeutic response and in radiation physics.

Learn how our scientists are revolutionizing cancer research and how you can HELP.

Clinical Research

The Department of Radiation Oncology is dedicated to providing the highest quality of patient care. To continue to improve treatment, and our patient’s lives, Physician-scientists in the Department are developing new technologies and clinical protocols and are involved in CINJ-initiated, national and internationally sponsored clinical trials. These trials are designed to improve treatment and our patient’s lives, and are formally reviewed and approved by an Institutional Review Board (IRB).

Learn more about current Clinical Trials and how you can HELP our fight against cancer.